Regenerative Medicine
Regenyx
HQ Location:
Israel
CEO
Yaron Rapaport
EST.
2019
Lead Product:
Lipogenyx — a matrix-enhanced fat-grafting scaffold / “fat viability extender” built on proprietary synthetic peptide hydrogel technology.
Regenyx Medical is developing regenerative solutions for minimally invasive soft-tissue restoration. Its lead product, Lipogenyx, is designed to improve fat graft survival, integration, and long-term outcomes in reconstructive and aesthetic procedures by combining autologous fat with a proprietary peptide hydrogel scaffold.

